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Abstract: Chalcones are polyphenolic secondary metabolites of plants, many of which have 
antioxidant activity. Herein, a set of 26 synthetic chalcone derivatives with alkyl substituted 
pyrazine heterocycle A and four types of the monophenolic ring B, were evaluated for the potential 
radical scavenging and antioxidant cellular capacity influencing the growth of cells exposed to 
H2O2. Before that, compounds were screened for cytotoxicity on THP-1 and HepG2 cell lines. Most 
of them were not cytotoxic in an overnight MTS assay. However, three of them, 4a, 4c and 4e 
showed 1,1-diphenyl-2-picrylhydrazyl (DPPH●) radical scavenging activity, through single 
electron transfer followed by a proton transfer (SET-PT) mechanism as revealed by density 
functional theory (DFT) modeling. DFT modeling of radical scavenging mechanisms was done at 
the SMD//(U)M052X/6-311++G** level. The in vitro effects of 4a, 4c and 4e on the growth of THP-1 
cells during four days pre- or post-treatment with H2O2 were examined daily with the trypan blue 
exclusion assay. Their various cellular effects reflect differences in their radical scavenging capacity 
and molecular lipophilicity (clogP) and depend upon the cellular redox status. The applied simple 
in vitro-in silico screening cascade enables fast identification and initial characterization of potent 
radical scavengers. 
Keywords: antioxidant; chalcone-like; DFT; in silico; in vitro; pyrazine; radical scavenging 
 
1. Introduction 
Chalcones are molecules containing a 1,3-diphenylprop-2-en-1-one fragment (Figure 1). They 
are natural products from the group of flavonoids. Plenty of chalcones have been isolated from 
natural plant sources [1]. However, numerous synthetic chalcone derivatives with various 
substitutions at the benzene rings or with heterocyclic analogs have also been prepared in 
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laboratories [2]. From the synthetic aspect, the advantage of chalcones is the structural versatility 
generated by relatively simple synthetic procedures [2–4]. 
 
Figure 1. Natural chalcone antioxidants [1]. The 1,3-diphenylprop-2-en-1-one fragment is marked 
red and the atom numbering used for all studied compounds is labelled. 
Herein, we have considered chalcone-like compounds with non-substituted or 4′-alkyl 
substituted pyrazine heterocycle at the place of benzene ring A (Figure 1, Table 1). Some biological 
activities of these synthetic derivatives have already been described. Chalcones and their various 
heterocyclic analogues exert modulatory effects on different molecular targets depending on the 
aromatic system types and the substitution pattern [4,5]. The pyrazine analogues of chalcones have 
been screened for antimicrobial and antifungal activity, but the derivatives considered here have 
shown no significant anti-infective effects [6–8]. Antiproliferative activity of chalcones has also been 
tested on various cancer cell lines [9]. Chalcones exert cytotoxic effects on various cancer cell lines 
and their use as antitumor agents with various molecular mechanisms of action, has been discussed 
in several recently published reviews [5,10,11]. However, many chalcones with significant 
pharmacological effects are not toxic to non-tumorous cells and for that reason chalcones are 
suggested for cancer chemoprevention [1,12]. Cancer chemopreventative activity has been 
demonstrated for natural chalcones, e.g., xanthohumol (Humulus lupulus, Cannabaceae), naringenin 
chalcone and its glucoside isosalipurpuroside (Helichrysum maracandicum, Asteraceae), 
isobavachalcone (Angelica keiskei, Apiaceae), as well as for various synthetic hydroxylated and 
methoxylated chalcones (Figure 1) [13–15]. Chemopreventative effects of chalcones have been 
recognized in respect to their interference with cellular mechanisms involved in mutagenesis and/or 
the repair of damaged DNA, as well as with chalcone related increases in phase 2 metabolic enzyme 
activity [16]. 
Table 1. The pyrazine analogues of chalcones tested for cytotoxicity against cell lines HepG2 and 
THP-1 (IC50 (μM)) and on DPPH● radical scavenging (RS) activity (IC50 (μM)). Their lipophilicity was 
estimated in silico. 
Compound X R1 R2 HepG2 THP-1 DPPH● 1 clogP 2 
 
1 CH H 2-OH >100 70 >1000 2.96 
1a N H 2-OH >100 40 >1000 1.01 
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1b N propyl 2-OH >100 >100  2.28 
1c N isopropyl 2-OH >100 96 >1000 2.25 
1d N butyl 2-OH 86 27 >1000 2.73 
1e N isobutyl 2-OH >100 94  2.50 
1f N tert- butyl 2-OH >100 >100  2.65 
2 CH H 3-OH >100 51 >1000 2.96 
2a N H 3-OH 100 50 >1000 1.01 
2b N propyl 3-OH >100 48  2.28 
2c N isopropyl 3-OH 97 83 >1000 2.25 
2d N butyl 3-OH >100 67 >1000 2.73 
2e N isobutyl 3-OH >100 >100  2.50 
2f N tert- butyl 3-OH >100 >100  2.65 
3 CH H 4-OH >100 >100 >1000 2.96 
3a N H 4-OH >100 97 >1000 1.01 
3b N propyl 4-OH >100 94  2.28 
3c N isopropyl 4-OH >100 78 >1000 2.25 
3d N butyl 4-OH >100 83 >1000 2.73 
3e N isobutyl 4-OH >100 >100  2.50 
3f N tert- butyl 4-OH >100 >100  2.65 
4 CH H 3-OCH3, 4-OH >100 >100  2.89 
4a N H 3-OCH3, 4-OH >100 >100 186 0.94 
4c N isopropyl 3-OCH3, 4-OH >100 >100 39 2.18 
4e N isobutyl 3-OCH3, 4-OH >100 >100 46 2.43 
4f N tert- butyl 3-OCH3, 4-OH >100 36  2.58 
1 The IC50 for vitamin C is 15 μM. 2 Values of molecular lipophilicity (clogP) were calculated by 
DataWarrior [17]. 
Biological effects of chalcones have also been ascribed to their antioxidative activities [18]. 
Chalcones exert indirect and direct redox activities. They are inhibitors of aldose reductase ALR2, an 
enzyme with antioxidative and anti-inflammatory effects [19–21]. There are also chalcones with 
direct radical scavenging (RS) activities [18,22]. The direct RS activity of natural chalcones such as 
prenylated xanthohumol [15], non-prenylated butein [15,23] or various licorice chalcones is 
well-documented [24]. The presence of free hydroxyl groups (at C-2′ in the ring A and a catechol 
group in the ring B) and the α,β-double bond in the linker are considered important structural 
features for efficient antiradical activity of chalcones [15]. 
The aim of our study was to explore the antioxidant potential associated with the RS 
mechanism for the set of synthetic pyrazine analogues of chalcones [19,25]. Their antioxidant 
activities were measured in vitro through direct reaction with a 1,1-diphenyl-2-picrylhydrazyl 
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radical (DPPH•) and additionally in the THP-1 cellular assay treated with hydrogen peroxide 
(H2O2). The RS mechanism was characterized by performing quantum-chemical density functional 
theory (DFT) modeling. The observed difference in antioxidant cellular activity of good radical 
scavengers was ascribed to differences in their RS capacity and molecular lipophilicity. 
2. Materials and Methods 
2.1. Studied Compounds 
All studied chalcone and chalcone-like compounds were synthesized previously according to 
the cited references [6–8,19]. The structural characteristics of all compounds (melting points, IR and 
NMR data) are available: for compounds 1, 2, 3 and 4 in the supplementary material of Reference 
[19], 1a, 1b, 1d, 1e, 1f, 3a, 3b, 3d, 3e, 3f, 4a, 4e and 4f in Reference [6], 2a, 2b, 2d, 2e and 2f in Reference 
[7] and 1c, 2c, 3c and 4c in Reference [8]. The compounds were dissolved in dimethyl sulfoxide 
(DMSO). 
2.2. Cell Lines 
Adherent liver hepatocellular carcinoma cell line HepG2 (ATCC, HB-8065) and human acute 
monocytic leukemia cell line in suspension THP-1 (ATCC, TIB-202) were purchased from American 
Type Culture Collection (ATCC, Manassas, USA). Cell lines were maintained in complete 
DMEM/F12 medium (Sigma, D8437, St. Louis, USA) and complete RPMI1640 (Sigma, R7388, St. 
Louis, USA) respectively, supplemented with 10% Fetal Calf Serum (FCS, Sigma, F7524, St. Louis, 
USA) at 37 °C in 5% CO2 atmosphere. 
2.3. Cytotoxic Activity 
A cytotoxicity assay was performed using MTS CellTiter 96 AQueous One Solution Cell 
Proliferation Assay (Promega, G3580, Madison, USA) [26]. Double dilutions of compounds were 
prepared in the concentration range of 100–0.2 μM within microplate wells. In each well, 5 × 104 cells 
were added and the plates were incubated overnight at 37 °C in 5% CO2 atmosphere. Following this, 
10 μL of MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H 
-tetrazolium) reagent was dispensed per well and the plates were incubated for 1–6 h at 37 °C in 5% 
CO2 atmosphere. Control wells consisted of media only (blank) or cells with 1% DMSO added 
(control). The absorbance was recorded at 490 nm using a Wallac Victor2 microplate reader 
(PerkinElmer, Waltham, USA). Results were analyzed in GraphPad Prism software (GraphPad 
Software, San Diego, USA). 
2.4. DPPH• Radical Scavenging Assay 
The DPPH (1,1-diphenyl-2-picrylhydrazyl, Sigma, D9132, St. Louis, USA) method was used to 
determine the RS activity of compounds [27]. Vitamin C (Acros Organics, Geel, Belgium) was used 
as a standard antioxidant control and was prepared in the same way as tested compounds. Dilutions 
of tested compounds and vitamin C were prepared in a final concentration range of 1 mM–0.01 μM. 
One milliliter of compound solution was added to 1 mL of freshly prepared DPPH• solution (3.9 
mg/50 mL ethanol; final concentration of 100 μM) and the reaction mixture was incubated in the 
dark at room temperature for 30 min. Absorbance was recorded at 540 nm using a 96-well Wallac 
Victor2 plate reader. Neutralization of DPPH• radical by a compound was calculated according to 
the following formula: 
RS activity (%) = [(A0 − A1)/A0] × 100  
 
(1) 
where A0/A1 is the control/sample absorbance. The results were averages of three measurements. 
The IC50 value was calculated using GraphPad Prism software (GraphPad Software, San Diego, 
USA). 
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2.5. Effects of Compounds on the Growth of THP-1 Cells Treated with H2O2 
The substances without cytotoxic effects and with RS activity were tested for antioxidant 
potential at the cellular level using THP-1 cells treated by H2O2 [28]. The cells were exposed to the 
IC50 concentrations of the compounds determined by the DPPH• assay. Compounds were applied 
30 min either before or after exposure to 5 mM of H2O2, which is equivalent to the cytotoxic ED50 
dose of H2O2 for the THP-1 cells [28]. The cell growth was analyzed every 24 h, via the trypan blue 
exclusion assay using a Bürker-Türk hemocytometer (Brand GMBH + CO KG, Wertheim, Germany), 
during a 4-day period. All assays were carried out in triplicates. The comparison of mean values was 
done by the two-tailed Student’s t-test. 
2.6. In Silico Methods 
2.6.1. Predictions of Physicochemical and ADME/Tox Properties 
Physicochemical and ADME/Tox (Absorption, Distribution, Metabolism and Excretion / 
Toxicity) parameters were predicted by the algorithms DataWarrior [17] and SwissADME [29]. 
Inputs for both algorithms were SMILES (simplified molecular-input line-entry system) 
(Supplementary Table S1). 
2.6.2. Molecular Similarity 
The MACCS fingerprint generation and molecular similarity clustering using binary distance 
were done by R packages rcdk and factoextra, respectively [30,31]. 
2.6.3. DFT Calculations 
The gas-phase (g) reaction parameters: bond dissociation enthalpy (BDE), ionization potential 
(IP), acidity and electron transfer enthalpy (ETE), as well as their aqueous (aq) free energy (FE) 
counterparts BDFEaq, IFEaq, pKa, and ETFEaq, respectively, were calculated by using thermochemical 
cycles [32] along with the DFT model (U)M052X/6-311++G** implemented in Gaussian 09 [33,34]. 
Equilibrium geometries in neutral and anionic closed-shell as well as neutral mono-radical and 
radical cation open-shell doublet ground electronic states, were optimized in the gas phase. The 
minima were confirmed by no imaginary vibrational frequencies. Calculations were done with the 
compounds in E-configuration [6–8,19]. The free energies of hydration ΔG*hyd were determined at 
the gas phase geometries by using the universal continuum solvation model SMD [35]. 
3. Results and Discussion 
3.1. In Vitro Cytotoxicity 
The cytotoxic effects of 26 compounds were evaluated by using the MTS test which has been 
run as a part of routine safety compound profiling [26,36]. The compounds (applied in 
concentrations up to 100 μM overnight) showed no considerable effects on cellular metabolism and 
viability of HepG2 and THP-1 cells (Table 1). None of compounds were cytotoxic against HepG2 
cells. In regard to THP-1 cells, stronger cytotoxicity was detected only for the two compounds: the 
2-OH substituted derivate 1d and the 3-OCH3, 4-OH substituted derivate 4f, for which the IC50 
values were 27 μM and 36 μM, respectively. In addition, compounds with single 2- or 3-OH group in 
the ring B showed, in average, somewhat stronger cytotoxicity as compared with the 4-OH 
analogues (Table 1) [37]. 
However, some of the studied compounds have been determined to exert cytotoxic effects 
during a longer incubation period (Figure 2) and/or against another cancer cell lines. For example, 
the chalcone 3 had significant cytotoxicity against cell lines A549, PC3, MCF-7, HT-29 and WRL68 
[9]. Many chalcone analogues with heteroaryl A or B ring(s) (e.g., indole or quinolone analogues) 
have also been reported to exhibit potent growth inhibitory activity on cancer cell lines [5,10]. 
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Figure 2. (a) The effects of the radical scavengers 4a, 4c and 4e and the oxidant H2O2 on the growth of 
THP-1 cells cultured for 96 h; (b–d) the effects of the compounds given 30 min either before 
(compound + H2O2) or after (H2O2 + compound) H2O2 on the THP-1 cells. 
3.2. In Vitro and in Silico Radical Scavenging Analysis 
The various types of redox activity of the studied pyrazine chalcone derivatives have been 
demonstrated so far [6,19]. Some of them inhibited the catalytic activity of aldose reductase ALR2. 
The pyrazine derivatives 2a and 3a showed moderate ALR2 inhibition activity. Regarding the 
corresponding chalcones, only 3 had comparable ALR2 inhibition. Neither chalcones nor their 
pyrazine analogues with 2-OH or 3-OCH3, 4-OH substitutions showed this activity. The 2-OH (series 
1) and 4-OH (series 3) substituted compounds with a 4′-alkylated pyrazine ring A (Table 1) were also 
found to impair the photosynthetic electron transport system in plants in the study of their herbicide 
activity, which was conducted since the pyrazine chalcone derivatives have common structural 
features with the cinnamoyl pyrazine plant growth inhibitors [6]. 
Chalcones have also been tested in various RS assays [19,38]. When tested in the assay of 
styrene auto-oxidation under oxygen atmosphere at 50 °C initiated by azo-bis-isobutyronitrile, 1a, 3a 
and 4a showed significant RS activity comparable to or even greater than that of the corresponding 
para-coumaric acid fragment [38]. Antioxidative activity of chalcones 3 and 4 and their pyrazine 
analogues 3a and 4a, respectively, have been measured in the DPPH• assay and the compounds 
with the guaiacyl-like ring B (series 4) were determined to have moderate RS capacity [19]. In our 
study, the DPPH• RS activity was measured for other synthesized derivatives as well (Table 1). 
Among all tested compounds, only the guaiacyl-substituted derivatives 4a, 4c and 4e have 
displayed DPPH• RS potential with IC50 values of 186 μM, 39 μM and 46 μM, respectively (Table 1). 
They were weaker DPPH• radical scavengers than the reference vitamin C which has an IC50 value 
of 15 μM. It is well-known that phenolic compounds with high RS activity generally have a catechol 
fragment [32,39–41]. The elimination of one of the catecholic OH groups e.g., by methylation, 
diminishes the RS capacity of polyphenols [40]. 
The obtained DPPH• RS data were interpreted and the underlying RS mechanism of the 
guaiacyl-substituted derivatives was determined by applying quantum-chemical modeling (Table 
2). Three mechanisms have been proposed for RS by phenolic compounds [32]. It has been proposed 
that neutral phenolic compounds may scavenge free radicals by donating an H-atom in a one-step 
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hydrogen-atom transfer (HAT) mechanism which is described by the O-H BDE parameter. In a 
simple model designed for the estimation of relative RS capacities, the parameter BDE is defined as a 
difference between a sum of enthalpies of the phenoxy radical and hydrogen atom products and an 
enthalpy of a neutral phenolic reactant [32]. Another proposed RS mechanism for neutral phenols is 
a two-step process composed of a single electron transfer followed by fast proton transfer from the 
positively charged radical intermediate (SET-PT). The first step is described by the ionization 
potential (IP) of a phenolic molecule. In the third proposed RS mechanism, the two-step sequential 
proton loss electron transfer (SPLET), following the first step of deprotonation of a phenolic group 
(described by its acidity constant), an intermediate anion donates an electron with capacity 
described by the parameter ET(F)E [32]. Assuming that 4′-alkyl substituents do not considerably 
influence the RS properties of the free -OH group in the ring B [41], the parameters were calculated 
for the compounds with an unsubstituted ring A (a-compounds) and their chalcone analogs (Table 
2). 
Table 2. Computed parameters (in kcal/mol) of O–H bond dissociation energy in the gas (g) and 
aqueous (aq) phases (BDEg, BDFEaq) and the electron donating capacity (ionization potential and 
electron transfer free energy) (IPg, ETFEaq) as well as acidity (pKa) of studied derivatives with 
unsubstituted pyrazine ring A (a) and corresponding chalcones, the guaiacyl derivatives 4c and 4e in 
addition to well-known antioxidants. 
Compound BDEg IPg BDFEaq IFEaq pKa ETFEaq 
1 84.9 188 85.7 107.8 10.9 77.5 
1a 85.7 192.5 82.9 106.9 8.4 78.1 
2 88.5 191.2 86.5 108.9 13.2 75.2 
2a 88.5 192 87.5 108.7 13.4 75.9 
3 85.2 184.6 83.9 103.5 11.1 77.5 
3a 85.4 188.4 84.4 102.8 10.7 76.6 
4 86 177.5 84.7 99.3 12.8 73.9 
4a 85.8 178.4 84.8 99.2 12.0 75.2 
4c 85.7 176.4 84.2 97.8 11.8 74.8 
4e 85.9 176.4 86.4 99.2 13.3 74.9 
Apigenin (4′-OH) 86.7 176.7 85.3 100.6 11.4 76.4 
Quercetin (4′-OH) 79.3 176 80.2 98.8 8.9 74.8 
Vitamin C  78.2 206.8 77.6 109 3.7 79.4 
By comparing the parameter values with those of the good radical scavengers, quercetin and 
vitamin C, only compounds with the guaiacyl group (series 4) are predicted to have moderate RS 
activity. This has been in agreement with the in vitro results (Table 1). Since the prediction is based 
on the comparison of the IPg and IFEaq values, the associated RS mechanism of these derivatives has 
been predicted to be SET-PT [32]. Although the ETFEaq values of most of the pyrazine derivatives are 
comparable with those of reference compounds (Table 2), since they are weak acids (pKa > 10.0 
except for 1a, Table 2), SPLET is not expected to be their dominant RS mechanisms. If it were an 
important RS mechanism, then the compounds with a 3-OH group would have also shown DPPH• 
RS activity. 
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3.3. Effects of Selected Compounds on the Growth of THP-1 Cells Pre- or Post-Treated with H2O2 
The three compounds 4a, 4c and 4e which were non-toxic for THP-1 cells after overnight 
incubation and had demonstrated RS activity, were further tested for the antioxidative activity using 
THP-1 based cellular assay (Figure 2). They were added at their DPPH• RS IC50 concentrations 
(Table 1) to THP-1 cells 30 min before or after H2O2. The aim of this part of the study was to see if the 
compounds may alter cytotoxic and growth suppressing effects of H2O2 as was recently described 
for antioxidative 1,4-dihydropyridine derivatives [42]. Although the three compounds are 
structurally similar (Figure 3), their effects on the growth of THP-1 cells through a four day period 
without or with the presence of H2O2 oxidant, were different. 
 
Figure 3. (a) Equilibrium ground-state structures (M052X/6-311++G**) with a Connolly surface 
(white parts correspond to nonpolar surface area) of the radical scavengers 4a, 4c and 4e; (b) 
Clustering of 26 compounds (Table 1) according to their structural similarity (more blue/red—more 
similar/dissimilar compounds). 
Considering antiproliferative effects of the pure substances, only 4e had no considerable effects 
on the growth of the THP-1 cells during a longer time period (Figure 2a). In the experiments with 
H2O2, all three compounds attenuated pro-oxidative activity of H2O2, except 4a when it was added to 
the cell culture after H2O2 (Figure 2b). The attenuating effects followed a similar pattern, but with a 
difference in magnitude. The lowest effect against cytotoxic activity of H2O2 was observed with 4a, 
which is the weakest radical scavenger and the least lipophilic molecule among them (Table 1). The 
most efficient reduction of cytotoxic effect of H2O2 was achieved with 4c when it was added before 
H2O2 (Figure 2c), possibly due to its strongest RS capacity. In this treatment, the number of the 
THP-1 cells did not decrease at all and remained higher than the respective values for the cells 
treated only with H2O2 during whole experiment. THP-1 cells in all cases (b)–(d) start to recover after 
initial damage at 48 h point, but the extent of their recovery was considerably greater in the case of 
cells treated with the compounds 4c and 4e. 
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Stronger antioxidative and cellular growth recovery effects of 4c and 4e as compared to 4a, may 
be associated with their higher RS capacity and additionally with their greater lipophilic character 
which may enable more extensive uptake of these compounds by THP-1 cells (Table 1, Figure 3) [43]. 
The alkyl isopropyl and isobutyl R1 substituents significantly increase molecular lipophilicity of 4c 
and 4e as compared with unsubstituted analog 4a (Table 1). 
The three guaiacyl-like derivatives as well as all other studied derivatives satisfy the Lipinski 
rule of five (Table S1). They are neutral molecules at pH 7.4 (except 1a, Table 2), moderately soluble 
in water and of moderate lipophilicity (Table S1). They are also not predicted to be substrates of the 
drug efflux pump P-glycoprotein. Thus, these alkyl-substituted pyrazine analogs of chalcones are 
expected to pass through cellular membranes including those of intestinal epithelial cells. None of 
the studied compounds are expected to cause mutagenic or tumorigenic effects (Table S1). However, 
as α,β-unsaturated carbonyls, these derivatives may also react as Michael acceptors with reactive 
sulfhydryl groups of glutathione or cysteine amino acid residues of proteins. Such modifications of 
biomolecules are associated with an induction of the transcription of phase 2 enzymes and elevation 
of glutathione. These are major protective cellular responses against toxic and carcinogenic 
substances and may also contribute to the observed antioxidant cellular effects of considered 
compounds [16,37]. The direct RS activity that the compounds contribute to the observed cellular 
effects is indicated through the greater attenuation of H2O2 effects by the stronger radical scavengers 
4c and 4e in the period up to 48 h (Figure 2). However, the greater recovery effects after 48 h in the 
case of THP-1 cells treated with these two compounds may suggest their bifunctional antioxidant 
role. After a long treatment, 4c and 4e may exert their antioxidant activity through the activation of 
the Kelch-like ECH-associated protein 1 (Keap1)/ Nuclear factor erythroid 2-related factor 2 (Nrf2)  
pathway. Some chalcones and chalcone-like derivatives have already been found to activate the 
Keap1/Nrf2 antioxidant response element (ARE) pathway through a Michael addition to the 
cysteine residues of Keap1, which is a redox sensor and negative regulator of Nrf2 [44,45]. 
4. Conclusions 
The chalcone skeleton is a privileged scaffold in medicinal chemistry [1,2]. Many chalcone 
derivatives have shown biological activities (anti-infective, anticancer, anti-inflammatory) that may 
be associated with their antioxidant efficiency [11]. By applying the efficient and relatively 
inexpensive in vitro–in silico screening cascade, we determined antioxidant profiles for the set of 
non-cytotoxic pyrazine analogs of chalcones and analyzed them in terms of calculated RS 
parameters and molecular properties. Only derivatives 4a, 4c and 4e with a monomethylated 
catechol group in the ring B had DPPH• RS activity (Table 1) [15]. According to the 
quantum-chemical modeling, their RS mechanism corresponds to the two-step single electron 
transfer followed by proton transfer (SET-PT) pathway (Table 2). At the cellular level, the extent of 
attenuating effects against pro-oxidant H2O2, observed for radical scavengers 4a, 4c and 4e (Figure 2) 
were in agreement with their relative RS capacities and molecular lipophilicity (clogP) and depend 
also on the redox status of the cell. The screening cascade combining in vitro assays with proper in 
silico methods provided the efficient platform for identification and initial characterization of 
antioxidant properties of the studied compounds. 
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